● In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
● For a short-term investment strategy, the company has poor fundamentals.
●
Strengths
●
●
●
●
Weaknesses
● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● Low profitability weakens the company.
● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
● The company's "enterprise value to sales" ratio is among the highest in the world.
● The company is not the most generous with respect to shareholders' compensation.
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
● Most analysts recommend that the stock should be sold or reduced.
● The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
●
● The company's earnings releases usually do not meet expectations.